HNF4A and hepatitis B virus infection: A recent study involving in vitro experiments confirmed that luteolin can establish a signal cascade composed of ERK and HNF4α for the treatment of hepatitis B, and these findings have been verified through in vivo experiments, which shows that luteolin can inhibit HBV replication and can be used to fight hepatitis B26.